Wang, P., Liu, X., Sun, W., Dong, X., Tan, J., Chen, M., . . . Cui, H. (2026). Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease. Journal of Diabetes Research, 2026, 1. https://doi.org/10.1155/jdr/2131566
Chicago Style (17th ed.) CitationWang, Pingping, et al. "Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease." Journal of Diabetes Research 2026 (2026): 1. https://doi.org/10.1155/jdr/2131566.
MLA (9th ed.) CitationWang, Pingping, et al. "Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease." Journal of Diabetes Research, vol. 2026, 2026, p. 1, https://doi.org/10.1155/jdr/2131566.